Sangamo Therapeutics Inc (NASDAQ:SGMO)

15.80
BATS BZX Real-Time Price
As of 1:07pm ET
 -0.70 / -4.24%
Today’s Change
8.00
Today|||52-Week Range
27.50
-3.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-12.5M-12.4M-13.1M-20.2M
 
 
 
 
 
Depreciation317.0K412.0K468.0K588.0K
 
 
 
 
 
Total Other Cash Flow1.9M1.8M1.9M2.8M
 
 
 
 
 
Funds From Operations-10.3M-10.1M-10.7M-16.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-67.1M5.6M6.1M1.3M
 
 
 
 
 
Net Cash Flow - Operating Activities56.8M-15.7M-16.8M-18.1M
 
 
 
 
 
 
InvestingIncrease In Investments-120.2M-70.4M-22.7M-63.4M
 
 
 
 
 
Decrease In Investments37.5M44.1M51.6M54.5M
 
 
 
 
 
Capital Expenditures-1.7M-698.0K-878.0K-2.6M
 
 
 
 
 
Other Investing - Uses0.000.00-3.5M0.00
 
 
Net Cash Flow Investing-84.4M-27.1M24.5M-11.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale78.9M2.8M13.0M10.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----0.00----
Other Uses - Financing3.0K-7.0K654.0K14.0K
 
 
 
 
 
Net Cash Flow - Financing78.9M2.8M12.3M10.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash51.4M-39.9M19.9M-19.1M